eprocliv 50 mg/850 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
vimetso 50 mg/850 mg filmsko obložene tablete
metformin; vildagliptin - filmsko obložena tableta - metformin 662,88 mg / 1 tableta vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin
aglurab 850 mg filmsko obložene tablete
medis, d.o.o. - metformin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta - metformin
siofor 500 mg filmsko obložene tablete
berlin-chemie ag - metformin - filmsko obložena tableta - metformin 390 mg / 1 tableta - metformin
siofor 500 mg filmsko obložene tablete
berlin-chemie ag - metformin - filmsko obložena tableta - metformin 390 mg / 1 tableta - metformin
glucophage 850 mg filmsko obložene tablete
merck d.o.o. - metformin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta - metformin
siofor 850 mg filmsko obložene tablete
berlin-chemie ag - metformin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta - metformin
siofor 850 mg filmsko obložene tablete
berlin-chemie ag - metformin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta - metformin
vilspox 50 mg/1000 mg filmsko obložene tablete
sandoz d.d. - metformin; vidagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta vidagliptin50 mg / 1 tableta; vidagliptin 50 mg / 1 tableta - metformin in vildagliptin
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.